Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
My north star: We disclose—fast, fully, and on our terms. The “wait for more data” option is a mirage. It exposes the company to criminal liability under FDA adverse-event reporting rules, potential DOJ investigation, securities fraud charges, and derivative litigation that could destroy the firm.Read the full answer
CEO ACTION PLAN: 48-HOUR CRISIS RESPONSE My Core Decision: IMMEDIATE VOLUNTARY DISCLOSURE Reasoning: This is not a close call. We have a known serious safety signal affecting real patients right now. Every day we delay, approximately 27 additional patients (4M ÷ 8,000 ÷ 5 years × 365) are exposed to undisclosed risk.Read the full answer